Schering-Plough submits NDAs for desloratadine

Sepracor (SEPR) partner Schering-Plough (SGP) submitted separate NDAs to the FDA for two formulations of desloratadine nonsedating antihistamine. The first NDA is for desloratadine syrup to treat seas...